Montelukast Sodium and Levocetirizine Hydrochloride tablets i.e. Zinte-M tablet is a combination of Levocetirizine Hydrochloride and Montelukast sodium molecules, it is an anti-allergic and antihistamine tablet. It is used to treat sneezing and runny nose brought on by allergies, hay…
Azithromycin Tablets 250mg, also known as Azifon-250 tablets, is a widely used broad-spectrum macrolide antibiotic that effectively treats bacterial infections, particularly those affecting the respiratory system, skin, soft tissues, and genitourinary tract. They are commonly prescribed for conditions such as pneumonia, bronchitis,…
The government set up a department called the National Pharmaceutical Pricing Authority (NPPA) to control the prices of medicines in India. This department is tasked with making sure medicine is affordable but also available to everyone. Therefore, NPPA revised the…
A decent working pharma unit for sale in Himachal Una. It is a newly installed unit that is valid till 2027. The unit is a compact mid-size company that has a minimum cost of functioning in terms of monthly expenses.…
In a surprise order vide gazzete notification, the Health and Family Welfare Ministry, Government of India issued a 156 FDCs ban drugs list 2024. , The matter was examined by an Expert Committee appointed by the Central Government and the…
A good reputed Injection manufacturing top pharma company in Uttarakhand for sale. The company is situated in Haridwar district of Uttarakhand. It is a good option for futuristic investment purposes in the pharmaceutical manufacturing industry. It has multiple sections approved…
In the month of March 2024, NPPA the supreme body responsible for fixing the ceiling price of medicines in India announced an increase of 0.00551% increase in the existing prices of medicines that are covered under DPCO Order 2013. In…
The National Pharmaceutical Pricing Authority (NPPA) fixed the ceiling price of 39 formulations under the Drug Price Control Order 2013. As per the Order No. S.O. 423 (E) on February 02, 2024, ” In exercise of the powers conferred by…
For pharmaceutical manufacturers in India, complying with Schedule M – the cornerstone of Good Manufacturing Practices (GMP) – has long been the game. But the winds of change have blown, ushering in a revised Schedule M, promising a more robust…
What are the key features of Revised Schedule M for manufacturing companies? Ministry of Health and Family Welfare, Government of India, issued a notification regarding the implementation of revised Schedule-M 2024 by all pharmaceutical formulation companies in India. The initial…